コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 There was no difference in plasma corticosterone.
2 vated-mice exhibited a threefold increase in plasma corticosterone.
3 and vasopressin neurons along with decreased plasma corticosterone.
4 essor without altering the diurnal rhythm in plasma corticosterone.
5 7:00 and 19:00 h to assess diurnal rhythm of plasma corticosterone.
6 +/- 5 beats min(-1), saline versus Dex) and plasma corticosterone (5 +/- 2 versus 24 +/- 4 microg dl
7 icotropin releasing factor--CRF) levels, and plasma corticosterone activation in El and ddY mice in a
9 glands resulted in a significant decrease in plasma corticosterone and a consequent increase in ACTH,
10 on (100 ng, i.p.) induced large increases in plasma corticosterone and a substantial, but short-lived
11 ats, and the slope of the regression between plasma corticosterone and ACTH increased from am to pm a
12 oise exposures led to similar habituation of plasma corticosterone and ACTH responses, heart rate, an
14 weighed and blood collected for analysis of plasma corticosterone and adrenocorticotropic hormone (A
16 examine HPA axis responses as determined by plasma corticosterone and adrenocorticotropin hormone (A
21 rols, defeated B6 females exhibited elevated plasma corticosterone and increased c-Fos activation in
22 he WS-induced burying response and increased plasma corticosterone and interleukin-1beta (IL-1beta).
24 MORKO mice showed a significant elevation in plasma corticosterone and pituitary proopiomelanocortin
25 this dose produced a significant increase in plasma corticosterone and plasma glucose in both SHM and
26 g, i.v.) produced dose-related elevations in plasma corticosterone and prolactin; these hormonal resp
27 elevated behavioral emotionality, high basal plasma corticosterone and reduced gene expression of Bdn
28 ween electric footshock-induced increases in plasma corticosterone and the acquisition, or lack there
30 lline methiodide (BMI) resulted in increased plasma corticosterone and, in contrast to NE treatment,
31 uate nucleus neuropeptide Y mRNA expression, plasma corticosterone, and glucagon levels together with
32 ated swim produced a persistent elevation in plasma corticosterone, and, consistent with prolonged bl
33 s of arginine vasopressin within the SCN and plasma corticosterone are both markedly phase advanced i
34 lase (Th)], glucocorticoid receptor (GR) and plasma corticosterone, as well as brain-derived neurotro
35 wever, vagotomy did not alter stimulation of plasma corticosterone at 1 or 2 h after low-dose IL-1 be
36 arginine-vasopressin (AVP), plasma ACTH and plasma corticosterone (B) were measured in four and 24 m
39 aternal separation would elevate anxiety and plasma corticosterone compared to a nonhandled group.
41 Increased BNST CRF expression did not affect plasma corticosterone concentration but did decrease CRF
45 wever, in the corticosterone implanted rats, plasma corticosterone concentrations at 45 and 90 min po
46 ees C, and measured cloacal temperatures and plasma corticosterone concentrations at baseline and aft
47 These mice have approximately 80% higher plasma corticosterone concentrations compared with wild-
48 st body temperature can significantly affect plasma corticosterone concentrations in reptiles, which
49 s of overt toxicity, significantly increased plasma corticosterone concentrations in SHM rats up to 4
50 ed from crossing heterozygotes displayed low plasma corticosterone concentrations resulting from a ma
51 OT deficient (OT-/-) female mice had higher plasma corticosterone concentrations than wild type (OT+
52 enal (HPA) axis activity, with elevated mean plasma corticosterone concentrations that resulted from
54 carboetomidate, and vehicle groups, whereas plasma corticosterone concentrations were briefly (60-12
60 to 29 degrees C showed a robust increase in plasma corticosterone concentrations with restraint stre
61 treatment on body condition, immune metrics, plasma corticosterone concentrations, total antioxidant
64 ssion and post-traumatic stress disorder, on plasma corticosterone (CORT) and on c-fos mRNA and brain
65 While sex differences in stressor-induced plasma corticosterone (CORT) elevations and defensive be
66 f-administering rats displayed reduced basal plasma corticosterone (CORT) levels but showed an augmen
67 take and increases anxiety-like behavior and plasma corticosterone (cort) levels in rats, whereas cen
69 OF or ether fumes both produced increases in plasma corticosterone (CORT) levels; notably, peak level
71 blocked IS-induced increased CBT, increased plasma corticosterone (CORT), decreased CBG, aphagia and
72 e exhibited elevated and prolonged levels of plasma corticosterone (CORT), interleukin (IL)-6 and IL-
75 149+/-2 mmoles/L), with a marked increase in plasma corticosterone (e.g. male offspring; 11.9 [9.3-14
76 als on the EPM, and exhibited an increase in plasma corticosterone following EPM and restraint that w
78 Gipr(-/-) mice exhibited significantly lower plasma corticosterone, glucocorticoid-treated HF-fed Gip
81 nocorticotropic hormone replacement elevated plasma corticosterone in ghr-/-, compared with WT mice,
83 of corticosterone to the amygdala increases plasma corticosterone in response to a behavioral stress
84 Moreover, MIA males had delayed recovery of plasma corticosterone in response to a novel social enco
85 ted in the adrenal cortex of obese mice, and plasma corticosterone is increased, which can be counter
86 tory stage (ELHS), assessed by high baseline plasma corticosterone, is a potential mechanism to elici
87 nt stress, illustrated by a decrease of both plasma corticosterone level and c-fos expression in the
89 e found an increase in startle amplitude and plasma corticosterone levels 30 min following intra-BNST
90 El mice exhibited significantly elevated plasma corticosterone levels 60 min following exposure t
92 ticosterone content and abnormally increased plasma corticosterone levels after restraint stress, whe
93 Central administration of GLP-1 increases plasma corticosterone levels and elicits c-fos expressio
94 administration of NE provoked an increase in plasma corticosterone levels and Fos induction in the bo
96 t cocaine taking is associated with elevated plasma corticosterone levels and that systemic infusion
99 -like growth factor (IGF)-I are reduced, and plasma corticosterone levels are increased concomitantly
100 gous for the IL-6 transgene had normal basal plasma corticosterone levels but, after restraint stress
104 ntestinal polypeptide (VIP) had no effect on plasma corticosterone levels even in previously stressed
105 d female mice displayed similar increases in plasma corticosterone levels following CNSDS exposure re
106 This effect was accompanied by a rise in plasma corticosterone levels in a dose- and time-depende
107 havioral stress significantly increased peak plasma corticosterone levels in both groups to a similar
108 ales, but not males, also had elevated basal plasma corticosterone levels in comparison with controls
112 nduction of repeated transient elevations in plasma corticosterone levels mimicked the effects of rep
113 memory were not explained by differences in plasma corticosterone levels or numbers of Fos-labeled n
115 tion (LHSS) to evaluate whether the elevated plasma corticosterone levels that accompany food restric
121 s absence in adrenalectomized mice, in which plasma corticosterone levels were essentially undetectab
122 anxiety, depression and fear memory, and the plasma corticosterone levels were evaluated under both b
123 and a modest, but significant, elevation of plasma corticosterone levels were found at the nadir tim
125 Hippocampal MR and GR mRNA expression and plasma corticosterone levels were not significantly alte
126 al withdrawal symptoms or alterations in the plasma corticosterone levels were observed after 7 days
129 otropin at 20 hrs after the onset of sepsis, plasma corticosterone levels were similar to those in sh
130 ormone-deficient mice (CRH-/-) with very low plasma corticosterone levels would alter surfactant pool
132 reased startle hyperreactivity and decreased plasma corticosterone levels, similar to phenotypes exhi
133 ins responded to LPS by a 5-fold increase of plasma corticosterone levels, which were only moderately
140 xhibit high concentrations of stress-induced plasma corticosterone, linking this behavior to the stre
144 L administration without increases in either plasma corticosterone or aldosterone as normally seen in
145 s (anxiety-related behaviors), to changes in plasma corticosterone or glucose levels, or to altered a
146 ulenin did not prevent effects of fasting on plasma corticosterone or hypothalamic levels of neuropep
147 s to test the effects of body temperature on plasma corticosterone (predominant glucocorticoid in rep
149 ist had no effect on PACAP-induced increased plasma corticosterone, reduction of food intake, and bod
150 ed by the reduction of corticotropin-induced plasma corticosterone release and adrenal contents of cA
151 utilized to examine corticotropin-stimulated plasma corticosterone release as well as adrenal levels
153 ontrast, anterior BST lesions attenuated the plasma corticosterone response and decreased c-fos mRNA
154 maximum phase misalignment, the peak of the plasma corticosterone rhythm is shifted and the amplitud
155 eased basal, diurnal and stressor-stimulated plasma corticosterone secretion and basal plasma adrenoc
156 n behavior, but there was a marked effect on plasma corticosterone secretion between the groups.
157 to food-restricted rats and the magnitude of plasma corticosterone suppression was determined at two
158 taneous implants to chronically elevate free plasma corticosterone (the rodent homolog of cortisol; '
159 ng plasma ACTH and differentially regulating plasma corticosterone through an ACTH- and sympathetic n
161 ma corticosterone levels and the response of plasma corticosterone to exposure to the EPM and restrai
164 or 6 weeks (late) after adjuvant injection, plasma corticosterone was assayed and food intake was re
169 80% and elevated both tail-flick latency and plasma corticosterone when compared to saline-treated an